Bluebird Bio Cash Flow To Debt Ratio Over Time
| BLUE Stock | USD 0.38 0.01 2.56% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Bluebird Bio Performance and Bluebird Bio Correlation. Bluebird |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (34.93) | Revenue Per Share 0.357 | Quarterly Revenue Growth 1.337 | Return On Assets (0.36) | Return On Equity (1.87) |
The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Cash Flow To Debt Ratio Analysis
Compare Bluebird bio and related stocks such as Mersana Therapeutics, Zentalis Pharmaceuticals, and Y mAbs Therapeutics Cash Flow To Debt Ratio Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRSN | (13.9162) | (13.9162) | (13.9162) | (13.9162) | (13.9162) | (13.9162) | (13.9162) | (13.9162) | (13.9162) | (13.9162) | (14.7329) | (5.6299) | (1.9613) | (6.6934) | (7.03) |
| ZNTL | (3.466) | (3.466) | (3.466) | (3.466) | (3.466) | (3.466) | (3.466) | (3.466) | (3.466) | (3.466) | (3.466) | (3.466) | (3.6255) | (4.8163) | (5.06) |
| YMAB | (142) | (142) | (142) | (142) | (142) | (142) | (142) | (142) | (142) | (142) | (46.4044) | (57.5188) | (87.4666) | (30.1907) | (31.7) |
| TVTX | (4.3835) | (0.002) | (3.0932) | (0.5473) | (0.5473) | (0.0127) | (0.0359) | 0.1642 | (0.1147) | (0.2842) | (0.1985) | (0.0642) | (0.4572) | (0.7327) | (0.77) |
| MDGL | (62.933) | (2.8456) | (4.3654) | (3.3205) | (5.6932) | (1.4702) | (132) | (132) | (132) | (132) | (495) | (449) | (4.562) | (2.7949) | (2.93) |
| VKTX | (0.0047) | (0.0047) | (0.0047) | (0.2807) | (1.0147) | (4.0583) | (3.3861) | (4.2769) | (81.9603) | (81.9603) | (65.9909) | (1.6 K) | (159) | (226) | (238) |
| SRPT | (11.5217) | (12.855) | (16.9004) | (38.786) | (20.3127) | (6.3879) | (15.2211) | (0.5382) | (0.9242) | (0.6694) | 0.1083 | (0.404) | (0.2107) | (0.3989) | (0.42) |
| HEPA | (8.0E-4) | (8.0E-4) | (8.0E-4) | (10.8653) | (10.8653) | (10.8653) | (10.8653) | (10.8653) | (10.8653) | (28.3659) | (35.4181) | (117) | (652) | (353) | (370) |
| PTCT | (1.7766) | (1.7766) | (9.8153) | (958) | (1.3537) | (1.3537) | (1.0545) | (0.0694) | (0.1806) | (0.3143) | (0.6105) | (0.569) | (0.6106) | (0.0755) | (0.0793) |
| AGIO | (3.2607) | (3.2607) | (3.2607) | (3.2607) | (3.2607) | (3.2607) | (3.2607) | (3.2607) | (3.2607) | (3.2607) | (2.7639) | (4.1122) | (4.1122) | (4.73) | (4.97) |
| KPTI | (1.5499) | (1.5499) | (1.5499) | (1.5499) | (1.5499) | (1.5499) | (1.5499) | (1.5499) | (1.5499) | (1.7114) | (1.337) | (0.6242) | (0.8646) | (0.5322) | (0.56) |
| CVAC | (1.3375) | (1.3375) | (1.3375) | (1.3375) | (1.3375) | (1.3375) | (1.3375) | (1.3375) | (1.3375) | (1.3375) | (1.3375) | (1.3375) | (1.3375) | (1.2) | (1.26) |
| KRYS | (0.7113) | (0.7113) | (0.7113) | (0.7113) | (0.7113) | (0.7113) | (0.7113) | (38.9854) | (38.9854) | (38.9854) | (3.1662) | (64.426) | (64.426) | (60.2469) | (63.26) |
| VIR | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Bluebird bio and related stocks such as Mersana Therapeutics, Zentalis Pharmaceuticals, and Y mAbs Therapeutics Cash Flow To Debt Ratio description
My Equities
My Current Equities and Potential Positions
| Bluebird bio | BLUE |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.38
Check out Bluebird Bio Performance and Bluebird Bio Correlation. For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Bluebird Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.